Psoriatic arthritis: Pathogenesis and novel immunomodulatory approaches to treatment

Overview of attention for article published in Journal of Immune Based Therapies and Vaccines, September 2005

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)

Mentioned by

news: 55 news outlets

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 26 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 149 news stories from 55 outlets.

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

Yahoo! Finance USA, 08 Nov 2023

People living with treatment-resistant active psoriatic arthritis reported meaningful improvements in pain, physical function…

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

GlobeNewswire, 08 Nov 2023

Beerse, Belgium, Nov. 08, 2023 (GLOBE NEWSWIRE) -- FOR EUROPEAN AND UK MEDICAL AND TRADE MEDIA ONLY BEERSE, BELGIUM, 8 November…

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

Le Lézard, 08 Nov 2023

Janssen Pharmaceuticals, Inc., a Johnson

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

WNCT9, 08 Nov 2023

People living with treatment-resistant active psoriatic arthritis reported meaningful improvements in pain, physical function…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 145 additional news stories.